This Review discusses translational attempts to mitigate the inflammation that drives obesity-related cardiometabolic diseases. The Review also focuses on mechanisms that control inflammatory cascades, either through traditional anti-inflammatory drugs or via the specialized pro-resolving mediators that actively control the resolution of inflammation.
- Matúš Soták
- Madison Clark
- Emma Börgeson